These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

407 related items for PubMed ID: 9628270

  • 21. [Presence of markers predictive of type I pre-diabetes mellitus status in relatives of patients with type I diabetes mellitus].
    Rodríguez-Villar C, Conget I, Esmatjes E, Levy I, Calvet J, Figuerola D, Bergua M, Gutiérrez A, Miralles J, Millán M, Peig M, Gomis R.
    Med Clin (Barc); 1996 Sep 28; 107(10):371-4. PubMed ID: 9036240
    [Abstract] [Full Text] [Related]

  • 22. High T cell responses to the glutamic acid decarboxylase (GAD) isoform 67 reflect a hyperimmune state that precedes the onset of insulin-dependent diabetes.
    Honeyman MC, Stone N, de Aizpurua H, Rowley MJ, Harrison LC.
    J Autoimmun; 1997 Apr 28; 10(2):165-73. PubMed ID: 9185878
    [Abstract] [Full Text] [Related]

  • 23. Expression of GAD65 and islet cell antibody (ICA512) autoantibodies among cytoplasmic ICA+ relatives is associated with eligibility for the Diabetes Prevention Trial-Type 1.
    Yu L, Cuthbertson DD, Maclaren N, Jackson R, Palmer JP, Orban T, Eisenbarth GS, Krischer JP, DPT-1 Participating Investigators.
    Diabetes; 2001 Aug 28; 50(8):1735-40. PubMed ID: 11473032
    [Abstract] [Full Text] [Related]

  • 24. Altered immune response to insulin in newly diagnosed compared to insulin-treated diabetic patients and healthy control subjects.
    Schloot NC, Roep BO, Wegmann D, Yu L, Chase HP, Wang T, Eisenbarth GS.
    Diabetologia; 1997 May 28; 40(5):564-72. PubMed ID: 9165225
    [Abstract] [Full Text] [Related]

  • 25. Effects of insulin administration in a group of high-risk, non-diabetic, first-degree relatives of Type 1 diabetic patients: an open pilot trial.
    Rodríguez-Villar C, Conget I, Casamitjana R, Ercilla G, Gomis R.
    Diabet Med; 1999 Feb 28; 16(2):160-3. PubMed ID: 10229311
    [Abstract] [Full Text] [Related]

  • 26. First-degree relatives of persons with type 1 diabetes: insulin resistance and enterovirus infection are associated with different patterns of islet cell autoimmunity.
    Cubas-Dueñas I, Cabrera-Rode E, Sarmiento L, Molina G, Fonseca M, Arranz C, Domínguez E, González P, Vera M, Díaz-Horta O.
    Acta Diabetol; 2013 Apr 28; 50(2):233-9. PubMed ID: 21604002
    [Abstract] [Full Text] [Related]

  • 27. GADIA2-combi determination as first-line screening for improved prediction of type 1 diabetes in relatives.
    Dittler J, Seidel D, Schenker M, Ziegler AG.
    Diabetes; 1998 Apr 28; 47(4):592-7. PubMed ID: 9568692
    [Abstract] [Full Text] [Related]

  • 28. Combined screening for autoantibodies to IA-2 and antibodies to glutamic acid decarboxylase in first degree relatives of patients with IDDM. The DENIS Study Group. Deutsche Nikotinamid Interventions-Studie.
    Seissler J, Morgenthaler NG, Achenbach P, Lampeter EF, Glawe D, Payton M, Christie M, Scherbaum WA.
    Diabetologia; 1996 Nov 28; 39(11):1351-6. PubMed ID: 8933004
    [Abstract] [Full Text] [Related]

  • 29. Intervening before the onset of Type 1 diabetes: baseline data from the European Nicotinamide Diabetes Intervention Trial (ENDIT).
    European Nicotinamide Diabetes Intervention Trial Group.
    Diabetologia; 2003 Mar 28; 46(3):339-46. PubMed ID: 12687331
    [Abstract] [Full Text] [Related]

  • 30. Effects of insulin in relatives of patients with type 1 diabetes mellitus.
    Diabetes Prevention Trial--Type 1 Diabetes Study Group.
    N Engl J Med; 2002 May 30; 346(22):1685-91. PubMed ID: 12037147
    [Abstract] [Full Text] [Related]

  • 31. Negativation of type 1 diabetes-associated autoantibodies to glutamic acid decarboxylase and insulin in children treated with oral calcitriol.
    Papadimitriou DT, Marakaki C, Fretzayas A, Nicolaidou P, Papadimitriou A.
    J Diabetes; 2013 Sep 30; 5(3):344-8. PubMed ID: 23302101
    [Abstract] [Full Text] [Related]

  • 32. [Evaluation of the importance of antibodies against islet cells (ICA) and Glutamate Decarboxylase(anti-GAD) for determining prognosis of diabetes type 1 in the Polish population--5 year observation].
    Kretowski A, Szelachowska M, Kinalska I.
    Pol Arch Med Wewn; 1999 Apr 30; 101(4):323-7. PubMed ID: 10740410
    [Abstract] [Full Text] [Related]

  • 33. [The study of two immunological markers in patients with type-1 diabetes and in their first degree relatives].
    Cosmescu A, Graur M, Zlei M, Mătăsaru S, Felea D, Petroaie A, Slanină AM, Barbacariu L, Momanu O.
    Rev Med Chir Soc Med Nat Iasi; 2004 Apr 30; 108(3):549-53. PubMed ID: 15832972
    [Abstract] [Full Text] [Related]

  • 34. Validity of screening for individuals at risk for type I diabetes by combined analysis of antibodies to recombinant proteins.
    Christie MR, Roll U, Payton MA, Hatfield EC, Ziegler AG.
    Diabetes Care; 1997 Jun 30; 20(6):965-70. PubMed ID: 9167107
    [Abstract] [Full Text] [Related]

  • 35. Effects of high-dose oral insulin on immune responses in children at high risk for type 1 diabetes: the Pre-POINT randomized clinical trial.
    Bonifacio E, Ziegler AG, Klingensmith G, Schober E, Bingley PJ, Rottenkolber M, Theil A, Eugster A, Puff R, Peplow C, Buettner F, Lange K, Hasford J, Achenbach P, Pre-POINT Study Group.
    JAMA; 2015 Apr 21; 313(15):1541-9. PubMed ID: 25898052
    [Abstract] [Full Text] [Related]

  • 36. The Melbourne Pre-Diabetes Study: prediction of type 1 diabetes mellitus using antibody and metabolic testing.
    Colman PG, McNair P, Margetts H, Schmidli RS, Werther GA, Alford FP, Ward GM, Tait BD, Honeyman MC, Harrison LC.
    Med J Aust; 1998 Jul 20; 169(2):81-4. PubMed ID: 9700342
    [Abstract] [Full Text] [Related]

  • 37. Autoantibodies to glutamic acid decarboxylase and insulin in islet cell antibody positive presymptomatic type 1 diabetes mellitus: frequency and segregation by age and gender.
    Zimmet PZ, Elliott RB, Mackay IR, Tuomi T, Rowley MJ, Pilcher CC, Knowles WJ.
    Diabet Med; 1994 Nov 20; 11(9):866-71. PubMed ID: 7705024
    [Abstract] [Full Text] [Related]

  • 38. Optimized autoantibody-based risk assessment in family members. Implications for future intervention trials.
    Bingley PJ, Williams AJ, Gale EA.
    Diabetes Care; 1999 Nov 20; 22(11):1796-801. PubMed ID: 10546010
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Autoantibodies and human leucocyte antigen class II in first-degree family members of Mexican-American type 1 diabetic patients.
    Zeidler A, Raffel LJ, Costin G, Shaw SJ, Buchanan TA, Noble J, Rotter JI, Palmer J, Krischer JP, Wait C, Maclaren NK.
    J Clin Endocrinol Metab; 2001 Oct 20; 86(10):4957-62. PubMed ID: 11600569
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.